Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Emily J Gianatti"'
Autor:
Jemma Hudson, MSc, Moira Cruickshank, PhD, Richard Quinton, MD, Lorna Aucott, PhD, Magaly Aceves-Martins, PhD, Katie Gillies, PhD, Shalender Bhasin, ProfMB BS, Peter J Snyder, ProfMD, Susan S Ellenberg, ProfPhD, Mathis Grossmann, ProfPhD, Thomas G Travison, PhD, Emily J Gianatti, PhD, Yvonne T van der Schouw, ProfPhD, Marielle H Emmelot-Vonk, ProfPhD, Erik J Giltay, PhD, Geoff Hackett, FRCPI, Sudarshan Ramachandran, PhD, Johan Svartberg, ProfPhD, Kerry L Hildreth, MD, Kristina Groti Antonic, PhD, Gerald B Brock, ProfMD, J Lisa Tenover, ProfMD, Hui Meng Tan, FRCS, Christopher Ho Chee Kong, FRCS, Wei Shen Tan, PhD, Leonard S Marks, ProfMD, Richard J Ross, ProfMD, Robert S Schwartz, ProfMD, Paul Manson, BA Hons, Stephen Roberts, PhD, Marianne Skovsager Andersen, ProfDmSci, Line Velling Magnussen, PhD, Rodolfo Hernández, PhD, Nick Oliver, ProfFRCP, Frederick Wu, ProfMD, Waljit S Dhillo, ProfPhD, Siladitya Bhattacharya, ProfMD, Miriam Brazzelli, PhD, Channa N Jayasena, PhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 3, Iss 6, Pp e381-e393 (2022)
Summary: Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide the most extensive individual participant dataset (IPD) of t
Externí odkaz:
https://doaj.org/article/70b4dbf3d7d14292b6edc7c0fd36828c
Autor:
Cathy Latino, Emily J. Gianatti, Shailender Mehta, Johnny Lo, Amanda Devine, Claus Christophersen
Publikováno v:
BMC Pregnancy and Childbirth, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Gestational Diabetes Mellitus (GDM) is prevalent with lasting health implications for the mother and offspring. Medical nutrition therapy is the foundation of GDM management yet achieving optimal glycaemic control often requires t
Externí odkaz:
https://doaj.org/article/d2c7c6c774914d1fb5b13bc1be51af0e
Autor:
Jemma Hudson, Moira Cruickshank, Richard Quinton, Lorna Aucott, Magaly Aceves-Martins, Katie Gillies, Shalender Bhasin, Peter J Snyder, Susan S Ellenberg, Mathis Grossmann, Thomas G Travison, Emily J Gianatti, Yvonne T van der Schouw, Marielle H Emmelot-Vonk, Erik J Giltay, Geoff Hackett, Sudarshan Ramachandran, Johan Svartberg, Kerry L Hildreth, Kristina Groti Antonic, Gerald B Brock, J Lisa Tenover, Hui Meng Tan, Christopher Ho Chee Kong, Wei Shen Tan, Leonard S Marks, Richard J Ross, Robert S Schwartz, Paul Manson, Stephen Roberts, Marianne Skovsager Andersen, Line Velling Magnussen, Rodolfo Hernández, Nick Oliver, Frederick Wu, Waljit S Dhillo, Siladitya Bhattacharya, Miriam Brazzelli, Channa N Jayasena
Publikováno v:
e393
e381
The Lancet Healthy Longevity, 3(6), E381-E393. ELSEVIER
e381
The Lancet Healthy Longevity, 3(6), E381-E393. ELSEVIER
Background: Testosterone is the standard treatment for male hypogonadism, but there is uncertainty about its cardiovascular safety due to inconsistent findings. We aimed to provide the most extensive individual participant dataset (IPD) of testostero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c764047f3c18b6eb328d259767027d8
https://hdl.handle.net/1887/3563715
https://hdl.handle.net/1887/3563715
Autor:
Mathis Grossmann, Emily J Gianatti
Publikováno v:
Diabetic Medicine. 37:174-186
Epidemiological studies consistently demonstrate that lowered serum testosterone is not only common in men with established Type 2 diabetes, but also predicts future diabetic risks and increased mortality. Preclinical studies report plausible mechani
Publikováno v:
Asian Journal of Andrology
The objective of the study was to assess the effect of T treatment on constitutional and sexual symptoms in men with type 2 diabetes (T2D).This was a randomized double-blind, parallel, placebo-controlled trial.The study was conducted at a tertiary re
Autor:
Mathis Grossmann, Emily J Gianatti, John M. Wentworth, Jeffrey D Zajac, Boyd Josef Gimnicher Strauss, Rudolf Hoermann, Philippe Dupuis
Publikováno v:
Diabetes Care. 37:2098-2107
OBJECTIVE To determine whether testosterone therapy improves glucose metabolism in men with type 2 diabetes (T2D) and lowered testosterone. RESEARCH DESIGN AND METHODS We conducted a randomized, double-blind, parallel, placebo-controlled trial in 88
Autor:
Rudolf Hoermann, Trang Vu, Ego Seeman, Emily J Gianatti, Jeffrey D Zajac, Sara Baqar, Emma J. Hamilton, Cherie Chiang, Mathis Grossmann, Ada S Cheung, R Sia, Sandra Iuliano-Burns
Publikováno v:
Osteoporosis International. 25:2027-2033
In this longitudinal case–control study, acute fracture was associated with low serum testosterone, which was transient in 43 % of men. While assessment of gonadal status is part of the assessment of bone fragility, measurement of testosterone in t
Autor:
Emily J Gianatti, Emma J. Hamilton, Mathis Grossmann, Jeffrey D Zajac, John M. Wentworth, Damien M Bolton, D. Lim-Joon, Boyd Josef Gimnicher Strauss
Publikováno v:
Clinical Endocrinology. 74:377-383
Summary Objective Androgen deprivation therapy (ADT) for prostate cancer is associated with increases in fat mass and risk of type 2 diabetes; however, the relationship between sex steroid deficiency and abdominal fat distribution remains controversi
Autor:
Jeffrey D Zajac, Mathis Grossmann, Ego Seeman, Damien M Bolton, Emily J Gianatti, Emma J. Hamilton, Ali Ghasem-Zadeh, Roger Zebaze, D. Lim-Joon
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:E456-E463
Androgen deprivation therapy (ADT) used in the treatment of prostate cancer reduces bone mineral density (BMD) and predisposes to fractures. The structural basis of the BMD deficit and bone fragility is uncertain.We investigated changes in bone micro
Autor:
Que T Lam, Rudolf Hoermann, Emily J Gianatti, Jeffrey D Zajac, Philippe Dupuis, Mathis Grossmann
Publikováno v:
Clinical endocrinology. 84(1)
To assess the effect of testosterone treatment on cardiac biomarkers in men with type 2 diabetes (T2D).Randomized double-blind, parallel, placebo-controlled trial.Men aged 35-70 years with T2D and a total testosterone level ≤12·0 nmol/l (346 ng/dl